Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on...
Read moreChugai Pharmaceutical announced that "Actemra® Subcutaneous Injection" , the humanized antihuman IL-6 receptor monoclonal antibody, successfully met the primary endpoint...
Read moreTakeda Licenses Global Rights to Outpost for Novel Clinical Stage Compound for the Potential Treatment of Stress Urinary Incontinence Frazier...
Read moreBioPh China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters...
Read moreFirst Product from Global Partnership to Deliver High-Quality Biosimilars to Help Meet Needs of Patients and Healthcare Systems Worldwide Merck...
Read moreIn a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage a leading global...
Read moreCompany Does Not Rely On Specialty Pharmacies For The Distribution of Its Brand Products -- 97% of Allergan U.S. Branded...
Read moreThe 9th Asian & Oceanic epilepsy Congress was recently concluded in Manilla, Phillipines. In this conference UCB had brought together...
Read moreSeniors who break a hip receive the best care in skilled nursing facilities with the most experience handling such fractures,...
Read moreGlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.